Additionally, the NAD+-dependent deacetylase SIRT2 can also govern the metabolic fitness of immune cells by blocking the activities of key enzymes in multiple metabolic pathways, thus impairing effector functions of tumor-reactive T cells in the tumor microenvironment. This evidence concerns the gene SIRT2 and neoplasm.